, seven such cases were identified in 234 318 sequential cervical smears screened, giving an incidence of I per 33 474 smears. Review of the published work confirms the rarity of this finding. However, it should be noted that psammoma bodies may have been underreported in the past, particularly in otherwise normal cases where they may have been missed, or in those cases where frank malignancy was suggested cytologically and their presence has simply not been commented upon. With our cases, 33 cases in total are reported since 1964. Of these, 13 cases were associated with benign conditions and 20 with malignant disease. This confirms the major disease associations observed by Kern. Ovarian lesions are the most commonly observed (11 malignant and 5 benign) but there is also a significant association with endometrial carcinomal. It is also interesting to speculate why psammoma bodies were found on cervical cytology and why their presence is such a rarity.
The most important factors in delineating benign from malignant cases appear to be the age of the patient and the type of cells accompanying the psammoma bodies on cytology, in particular the presence or absence of cellular atypia. The majority of benign conditions are seen in women of reproductive years, as in these cases. However, several malignant cases have been reported in women in their twenties, so careful surveillance is warranted in all cases. Thorough cytological assessment of all cellular elements accompanying the psammoma bodies is essential, since in most malignant cases there are cells suggestive of malignancy.
These cases exemplify the management dilemma facing the clinician when presented with a young patient who has psammoma bodies on routine cervical smear. In women who hope to bear further children, a wait-and-see policy may be reasonable. However, in view of the greater than 50% risk of malignancy associated with this presentation and the absence of more accurate methods to screen for preinvasive and invasive disease of the upper genital tract, this approach should be pursued with caution. Furthermore, in all reported cases with benign histology the final diagnosis was confirmed only after total abdominal hysterectomy and bilateral salpingo-oophorectomy, which cannot be regarded as conservative management in a younger patient. In the long search for effective hip arthroplasty, numerous prostheses have failed to stand the test of time. One such is the Judet prosthesis, which may still be encountered.
CASE HISTORY
A woman aged 85 was admitted after a fall and a pelvic X-ray was taken (Figure 1 ). The admitting medical team were unable to interpret the X-ray and orthopaedic trainees were similarly baffled, but an orthopaedic consultant identified the implants as modified Judet acrylic hemiarthroplasties. On further enquiry the patient disclosed that she had been 'born with hip problems' and had undergone bilateral hip replacements at St Bartholomew's Hospital in December 1949, the left preceding the right by four weeks. Since that time she had had no trouble with her hips and her difficulties with mobility arose from a slight residual weakness after a stroke together with chronic low back pain. On examination she had 500 of hip flexion bilaterally with 100 of abduction, internal and external rotation. All movements were pain free. No further orthopaedic input was required. COMMENT Judet described the use of an acrylic hemiarthroplasty in 19471. The original design was modified by 1950 with the inclusion of a steel pin to prevent stem breakage2 ( Figure 2) and was proposed as an alternative to the then popular Smith-Petersen cup arthroplasty3. Good early results (2-5 years) with a dramatic improvement in function for many patients were reported in a 400-case series in 19524. Scales and Zarek5 studied the Judet hip both biomechanically and clinically and concluded that Judet prostheses, and acrylic in particular, were inappropriate for use in hip arthroplasty. Apparently, however, the manufacture and quality control of the prostheses that they studied was inferior to that originally described.
The Judet prosthesis has been reported as surviving from 20 to 40 years6'7 and so its longevity is comparable to that of the Charnley prosthesis, which has currently the best record with survival greater than 20 years8. Unfortunately in each of the cases of long-term Judet survival the patients were symptomatic or the stem had broken, requiring reoperation. The X-ray appearance of the prostheses in this case makes it difficult to say whether the acrylic head had survived but the patient is symptom-free after 47 years. The history suggests that they were inserted at about the time the modified version of the prosthesis was introduced. Whilst a single case does not provide an argument for reconsideration of the Judet hip, it does show that not all patients conform to the expected statistics. Trainees should be aware that there are some very old and unusual prostheses still in situ.
